Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Supermax BhdSPMXF 46 Days Sales Outstanding is 29.62 as of Jun. 2026, which is 16% below its 10-year median of 35.17. GuruFocus rates SPMXF with a GF Score™ of 46/100 and a GF Value™ of $0.25. The stock has 5 warning signs investors should review. Among 811 Medical Devices & Instruments companies, Supermax Bhd ranks better than 88.9% on this metric.
Supermax Bhd's average Accounts Receivable for the
three
months ended in Jun. 2026 was $17.6 Mil. Supermax Bhd's Revenue for the
three
months ended in Jun. 2026 was $54.3 Mil.
Hence, Supermax Bhd's Days Sales Outstanding for the
three
months ended in Jun. 2026 was 29.62.
The historical rank and industry rank for Supermax Bhd's Days Sales Outstanding or its related term are showing as below:
SPMXF'
s Days Sales Outstanding Range Over the Past 10 Years
Min: 22.17 Med: 35.17 Max: 70.04
Current: 34.96
During the past 13 years, Supermax Bhd's highest Days Sales Outstanding was 70.04. The lowest was 22.17. And the median was 35.17.
SPMXF's Days Sales Outstanding is ranked better than 88.9% of 811
companies
in the Medical Devices & Instruments industry
Industry Median: 65.38
vs SPMXF: 34.96
Supermax Bhd's Days Sales Outstanding
declined
from Jun. 2025 (41.19) to Jun. 2026 (29.62).
Supermax Bhd (OTCPK:SPMXF) Days Sales Outstanding Explanation
For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.
Supermax Bhd Days Sales Outstanding Related Terms
Supermax Bhd Days Sales Outstanding Historical Data
* Premium members only.
The historical data trend for Supermax Bhd's Days Sales Outstanding can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SPMXF vs ISRG, BDX, RMD: Days Sales Outstanding Comparison
For the Medical Instruments & Supplies subindustry, Supermax Bhd's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Supermax Bhd Days Sales Outstanding vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Supermax Bhd's Days Sales Outstanding distribution charts can be found below:
* The bar in red indicates where Supermax Bhd's Days Sales Outstanding falls into.
Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Supermax Bhd (SPMXF) has a Days Sales Outstanding of 29.62 as of Jun. 2026. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on Supermax Bhd and its competitors. This is 16% below median its historical median of 35.17. Over the past decade, Supermax Bhd's Days Sales Outstanding has ranged from 22.17 to 70.04. According to the industry distribution chart, Supermax Bhd ranks #90 out of 811 companies in the Medical Devices & Instruments industry, placing it in the top 11.1%.
Is Supermax Bhd's Days Sales Outstanding too high?
Supermax Bhd's current Days Sales Outstanding of 29.62 is 16% below median its 10-year median of 35.17. Over the past 10 years, this metric has ranged from a low of 22.17 to a high of 70.04. The Medical Devices & Instruments industry median Days Sales Outstanding is 65.38. Supermax Bhd's value of 29.62 is 54.7% below this industry median. Based on the distribution chart, Supermax Bhd ranks #90 out of 811 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Supermax Bhd has a GF Score™ of 46/100, reflecting its overall financial health beyond just this single metric.
How does Supermax Bhd's Days Sales Outstanding compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Supermax Bhd ranks #90 out of 811 companies for Days Sales Outstanding. This places Supermax Bhd in the top 11% of its industry — outperforming the majority of peers. The industry median Days Sales Outstanding is 65.38. Supermax Bhd's value of 29.62 is 54.7% below this benchmark. Historically, Supermax Bhd's own Days Sales Outstanding has ranged from 22.17 to 70.04 over the past decade. While the company's 10-year median is 35.17 vs. the industry median of 65.38, Supermax Bhd has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Sales Outstanding for a Medical Devices & Instruments company?
The median Days Sales Outstanding among Medical Devices & Instruments companies is 65.38, based on 811 companies in the industry. Companies in the top quartile (top 25%) have a Days Sales Outstanding significantly above this median, while those in the bottom quartile fall well below. However, Days Sales Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Supermax Bhd's current Days Sales Outstanding of 29.62 is 54.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Sales Outstanding mean?
A high Days Sales Outstanding can signal that a stock is expensive relative to its fundamentals. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on Supermax Bhd and its competitors. For the Medical Devices & Instruments industry, the median Days Sales Outstanding is 65.38 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Supermax Bhd's current Days Sales Outstanding is 29.62, which is 16% below median its own 10-year median of 35.17. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Supermax Bhd stock overvalued right now?
Supermax Bhd (SPMXF) has a current Days Sales Outstanding of 29.62. The stock's GF Value™ is $0.25, compared to a current price of $0.15 — trading 40% below its estimated fair value. The current Days Sales Outstanding is 29.62, which is 16% below median its 10-year median of 35.17 and 54.7% below the Medical Devices & Instruments industry median of 65.38. Supermax Bhd's overall GF Score™ is 46/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Sales Outstanding calculated?
Days Sales Outstanding is calculated from a company's financial statements. For Supermax Bhd (SPMXF), the current Days Sales Outstanding is 29.62 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Supermax Bhd (SPMXF) Overvalued in 2026?
Based on GuruFocus' analysis, Supermax Bhd stock appears to be undervalued.
The current stock price of $0.15 is trading 40% below its estimated GF Value™ of $0.25.
Key valuation signals for SPMXF:
Days Sales Outstanding: 29.62 (16% below median its 10-year median of 35.17)
GF Value™: $0.25 vs. price of $0.15 (40% below fair value)
Industry Position: 54.7% below the Medical Devices & Instruments median (#90 of 811)
No single metric tells the full story. See the SPMXF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Supermax Corp Bhd is an investment holding company. Along with its subsidiaries, the company operates as an international manufacturer, distributor, and marketer of high-quality medical gloves and contact lenses. It offers various types of latex gloves, which are exported to numerous countries. The company is organized into the following reportable operating segments: manufacturing of gloves, which generates the majority of revenue; investment holding; trading of gloves; and others. Geographically, it derives the majority of its revenue from Europe, with the remainder coming from Africa, Asia and Oceania, and North, Central, and South America.
46GF Score
Get the complete analysis for SPMXF
Days Sales Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SPMXF has been successfully added to your 
